Research.Patient.info
Gastrointestinal Stromal Tumors (GIST) research hub
2 indexed studies · 2 currently recruiting
- recruitingPhase I and Phase II (Integrated)- First administration to humans
A Phase 1/2 Study of the Safety, Pharmacokinetics and Anti-Tumor Activity of the Oral KIT Inhibitor THE-630 in Patients with Advanced Gastrointestinal Stromal Tumors (GIST)
This study is testing a new medicine, THE-630, for people with a type of cancer called GIST. It's looking at how safe the medicine is, how it moves through the body, and if it helps shrink tumours. It's in early stages, checking different doses.
Spain · France - recruitingTherapeutic exploratory (Phase II)
A Phase II, single arm Study of avelumab in combination with Axitinib in Patients with unresectable/metastatic Gastrointestinal Stromal Tumor after failure of standard therapy - AXAGIST
This study looks at a new combination of two existing drugs, avelumab and axitinib, for people with a type of cancer called Gastrointestinal Stromal Tumor (GIST). It's for patients whose cancer has come back or spread after standard treatments haven't worked.
Italy · Poland